Novartis
This article was originally published in The Tan Sheet
Executive Summary
Consumer Health division hopes to submit data to FDA within 30-60 days showing Phytrol, a sterol-based, cholesterol-lowering functional food ingredient, is generally recognized as safe. The Swiss firm is aiming to launch a Phytrol-containing functional food line in the U.S. in 2000, similar to the Aviva line that recently debuted in the U.K. and Switzerland (1"The Tan Sheet" Nov. 22, p. 4). Novartis also has entered into partnerships with the University of Texas Medical Center at Galveston and Ball State University in Indiana to conduct U.S. clinical trials in the area of functional foods and herbals; the firm hopes to bring a line of herbals currently marketed under the Valverde name in Germany and Switzerland to the U.S. market by the third quarter of 2000. Novartis also has said it plans to launch of a line of pediatric OTCs, including dental care remedies, diaper-rash creams and anti-gas drops, under the Gerber brand
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning